Hospital Admission for Suspected Systemic MRSA Infection
This patient requires immediate hospital admission for intravenous antibiotics and evaluation for metastatic infection, as fever and tachycardia following failed outpatient management of a breast abscess indicates severe infection with systemic involvement. 1
Immediate Management Steps
Hospitalization Criteria Met
- Fever and elevated heart rate following failed oral antibiotic therapy (Keflex then Bactrim) plus I&D represents severe purulent skin and soft tissue infection requiring IV antibiotics 1
- The presence of systemic signs of infection (fever, tachycardia) after adequate drainage and two courses of oral antibiotics indicates treatment failure and potential for metastatic complications 1, 2
- According to IDSA guidelines, patients with systemic signs (temperature >38.5°C or heart rate >110 beats/minute) require parenteral therapy 1
Diagnostic Workup Required
- Obtain blood cultures immediately (at least 2 sets from separate venipunctures) before starting IV antibiotics 2, 3
- Culture any remaining purulent drainage from the abscess site if accessible 1, 2
- Consider imaging (ultrasound or CT) to evaluate for undrained fluid collections or deeper abscess formation 1
- If bacteremia is confirmed, obtain transthoracic echocardiography to evaluate for endocarditis, as S. aureus bacteremia causes endocarditis in approximately 12% of cases 3
Empiric Antibiotic Therapy
First-Line IV Treatment
Vancomycin 15-20 mg/kg IV every 8-12 hours (not to exceed 2g per dose) is the recommended empiric therapy for severe MRSA skin and soft tissue infections with systemic signs 1, 2
Alternative IV options if vancomycin is contraindicated:
- Daptomycin 4 mg/kg IV every 24 hours 1
- Linezolid 600 mg IV every 12 hours 1
- Ceftaroline 600 mg IV every 12 hours 1
Why Previous Antibiotics Failed
- Keflex (cephalexin) lacks activity against MRSA, which accounts for 87-93% of community-acquired S. aureus skin abscesses 4, 5
- While Bactrim (TMP-SMX) has MRSA activity, oral therapy is insufficient for severe infections with systemic signs 1
- The failure of two oral regimens plus I&D strongly suggests MRSA as the pathogen 2, 5
Source Control Evaluation
Surgical Re-evaluation
- Immediate surgical consultation to assess adequacy of initial drainage and evaluate for undrained collections or necrotizing infection 1
- Breast abscesses may have multiple loculations requiring repeat I&D or placement of drainage catheter 1
- If fever persists >48 hours on appropriate IV antibiotics, inadequate source control is the most likely cause 3, 6
Red Flags for Deeper Infection
Look for signs suggesting necrotizing fasciitis or deeper involvement:
- Skin sloughing, bullae, or crepitus 1
- Pain out of proportion to examination findings 1
- Rapid progression of erythema despite antibiotics 1
- Hypotension or organ dysfunction 1
Duration and De-escalation Strategy
Treatment Duration
- Minimum 7-10 days of IV therapy for complicated skin and soft tissue infection with bacteremia 1
- If blood cultures are positive, duration extends to 14 days minimum (or longer if endocarditis or other metastatic infection identified) 1, 3
- Clinical improvement markers: defervescence, decreasing tachycardia, resolution of erythema 1
Antibiotic Adjustment
- Once culture and susceptibility results return, if MSSA is identified, switch to cefazolin 1-2g IV every 8 hours or nafcillin/oxacillin 1-2g IV every 4-6 hours for superior outcomes 1, 3
- If MRSA is confirmed with vancomycin MIC ≤2 mcg/mL and clinical improvement occurs, continue vancomycin 1
- If no clinical response despite adequate source control, consider alternative agents (daptomycin, ceftaroline, or linezolid) regardless of reported susceptibility 1, 6
Common Pitfalls to Avoid
- Do not continue oral antibiotics in a patient with fever and tachycardia after failed outpatient therapy—this represents severe infection requiring IV treatment 1
- Do not assume adequate drainage from initial I&D; repeat imaging and surgical evaluation are critical 1
- Do not delay blood cultures waiting for imaging results 2, 3
- If bacteremia is documented, do not treat for less than 14 days, as shorter courses are associated with treatment failure and metastatic complications 1, 3